BioNTech has announced a major expansion of its UK footprint, pledging to invest up to £1 billion...
Author - Abby Davey
UK biotech investment remains resilient in H1 2025, says BIA...
The UK’s biotech sector has demonstrated resilience in the first half of 2025, according to the...
Siemens accelerates Verified Environmental Transparency with EPD...
Siemens has secured official approval from EPD-Global — the Norwegian programme operator for...
Southlake Health adopts Philips AI-enabled MRI to scale...
Southlake Health has selected the Philips Ambition X MR with BlueSeal technology — a helium-free 1...
uniQure’s AMT-130 Demonstrates Statistically Significant 75 %...
uniQure has announced positive topline results from its pivotal Phase I/II trial of AMT-130 for the...
Pioneering TIL Therapy Delivered for Metastatic Lung Cancer at...
HCA Healthcare UK has delivered its first Tumour-Infiltrating Lymphocyte (TIL) therapy for a...
Lilly launches TuneLab to accelerate AI-driven drug discovery...
Eli Lilly and Company has launched Lilly TuneLab, an artificial intelligence and machine learning...
Koselugo Recommended for EU Approval in Adults with NF1...
AstraZeneca’s Koselugo (selumetinib) has secured a positive recommendation from the European...
SAR446268 Earns US Fast Track Designation for Non-Congenital...
Sanofi is pleased to announce that the US Food and Drug Administration (FDA) has granted Fast Track...
Enhertu plus pertuzumab granted FDA Priority Review as potential...
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has...